CYH Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

03
Kurs $2.72
Marktkapitalisierung (MRQ) $384M
P/E (TTM) 1.5
EPS (TTM) $1.86
Umsatz (TTM) $11.98B
ROE (TTM) -16.7%
Verschuldungsgrad (MRQ) -6.9
52W-Spanne $2–$4

CYH Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

04
Spanne
Balken

Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.

Aktiensplits 1
Ex-Datum Split Typ
22. April 2016 121-for-100 Vorwärts

Über Community Health Systems, Inc. Common Stock Unternehmensübersicht von Wikipedia

05 · wikidata

Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.

On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.

Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.

History

Founding and early years (1985–2014)

E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.

The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.

In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.

In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.

In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.

In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.

In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.

On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.

It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.

Recent developments (2015–present)

On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.

In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.

After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.

On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.

In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.

In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.

In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.

On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.

On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.

On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.

In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.

On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.

On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.

In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.

In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.

Predatory liens practices

Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.

Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗

Wikidata ↗

SektorHealth Care BrancheHealth Care Mitarbeiter44.000 LandUS

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

06
Umsatz$12.48B
2016-12-31 → 2025-12-31
EPS$3.77
2016-12-31 → 2025-12-31
Freier Cashflow$208M
2016-12-31 → 2025-12-31
Nettogewinnmarge2.1%
2018-12-31 → 2025-12-31
Bewertung & Kennzahlen 07–12

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl 5-Jahres-Trend CYH 5-Jahres-Durchschnitt Peer-Median Fazit
P/E (TTM) 1.55-Jahres-Durchschnitt ≈3.4 ≈3.4 15.5 Unterbewertet
P/S (TTM) 0.05-Jahres-Durchschnitt ≈0.1 ≈0.1 1.2 Unterbewertet
K/B (MRQ) -0.35-Jahres-Durchschnitt ≈-0.5 ≈-0.5 · ·
EV / EBITDA 7.15-Jahres-Durchschnitt ≈13.1 ≈13.1 10.6 Unterbewertet
Kurs / FCF (TTM) -2.15-Jahres-Durchschnitt ≈-0.8 ≈-0.8 · ·
Kurs / Cashflow (TTM) 3.05-Jahres-Durchschnitt ≈-1.6 ≈-1.6 6.5 Unterbewertet
EV / Revenue (EV / Umsatz) 0.85-Jahres-Durchschnitt ≈1.0 ≈1.0 · ·
EV / FCF 50.55-Jahres-Durchschnitt ≈-4.9 ≈-4.9 · ·

Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.

Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median

Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR

13
Ex-DatumBetragWährungRendite
Dez 13, 2012$0,21USD≈0.84%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

14
Durchschn. Überraschung 37.9%
Nächster Bericht Okt 21, 2026
ZeitraumBerichtEPS ActualEPS est.Überraschung
30. Juni 2026 Jul 21, 2026 $-0.19 $-0.06 -201.1%
31. März 2026 $-0.48 $-0.10 -387.3%
31. Dezember 2025 $-0.01 $-0.10 90.5%
30. September 2025 $1.27 $-0.25 610.5%
30. Juni 2025 $-0.05 $-0.11 52.6%
31. März 2025 $-0.03 $-0.08 62.6%

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

15
Gewinn- und Verlustrechnung 13
Kennzahl Trend 2025202420232022202120202019201820172016
Revenue $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Cost of Revenue $1.86B$1.95B$1.99B$1.98B$2.04B$1.96B$2.15B$2.35B$2.67B$3.01B
Operating Expenses $11.00B$12.09B$11.53B$11.39B$10.97B$10.66B$12.56B$13.95B$17.23B$19.30B
Operating Income $1.49B$542M$957M$821M$1.40B$1.13B$650M$208M$-1.88B$-860M
Interest Income $2M$3M$2M$2M$3M$3M$3M$7M$11M$14M
Pretax Income $724M$-283M$207M$349M$499M$422M$-430M$-715M$-2.83B$-1.72B
Income Tax $48M$79M$191M$170M$131M$-185M$160M$-11M$-449M$-104M
Net Income $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
EPS (Basic) $3.81$-3.90$-1.02$0.35$1.82$4.43$-5.93$-6.99$-22.00$-15.54
EPS (Diluted) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Shares (Basic) 133,564,227132,101,768130,445,677128,808,387126,754,852115,491,022113,739,046112,728,274111,769,821110,730,971
Shares (Diluted) 135,012,240132,101,768130,445,677130,060,319130,597,410116,544,561113,739,046112,728,274111,769,821110,730,971
EBITDA $1.49B$542M$957M$821M$1.40B$1.13B$1.26B$908M$-1.02B$240M
Bilanz 26
Kennzahl Trend 2025202420232022202120202019201820172016
Cash & Equivalents $260M$37M$38M$118M$507M$1.68B$216M$196M$563M$238M
Receivables $2.08B$2.29B$2.23B$2.04B$2.06B$1.93B$2.26B$2.35B$2.38B$3.18B
Other Current Assets $381M$358M$275M$235M$269M$338M$358M$400M$462M$568M
Current Assets $3.23B$3.30B$3.21B$3.08B$3.48B$4.51B$3.43B$3.55B$4.07B$4.67B
PP&E (Net) $4.50B$4.78B$5.21B$5.37B$5.55B$5.32B$5.61B$6.14B$7.05B$8.15B
PP&E (Gross) $8.91B$9.16B$9.51B$9.64B$9.76B$9.35B$9.65B$10.30B$11.50B$12.42B
Accum. Depreciation $4.41B$4.38B$4.30B$4.27B$4.20B$4.03B$4.04B$4.16B$4.45B$4.27B
Goodwill $3.32B$3.79B$3.96B$4.17B$4.22B$4.22B$4.33B$4.56B$4.72B$6.52B
Intangibles $7M$15M$20M$2M····$10M$14M
Other Non-current Assets $2.10B$2.17B$2.05B$2.01B$1.91B$1.90B$2.21B$1.54B$1.54B$2.59B
Total Assets $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Accounts Payable $842M$913M$912M$773M$830M$783M$811M$887M$967M$995M
Accrued Liabilities ······$1.13B$1.09B$1.13B$1.23B
Current Liabilities $2.21B$2.35B$2.14B$2.19B$2.36B$2.81B$2.28B$2.39B$2.36B$2.89B
Capital Leases $537M$535M$563M$605M$535M$524M$487M$84M$287M$302M
Deferred Tax $25M$231M$369M$354M$192M$29M$200M$26M$19M$411M
Other Non-current Liabilities $891M$828M$739M$644M$827M$1.60B$894M$1.01B$1.36B$1.57B
Total Liabilities $14.04B$15.37B$15.28B$15.40B$16.03B$17.06B$17.25B$16.82B$17.61B$19.66B
Long-term Debt $10.40B$11.45B$11.49B$11.63B$12.14B$12.22B$13.40B$13.60B$13.91B$15.24B
Total Debt $10.38B$11.43B$11.47B$11.61B$12.11B$12.09B$13.38B···
Common Stock $1M$1M$1M$1M$1M$1M$1M$1M$1M$1M
Retained Earnings $-3.57B$-4.08B$-3.56B$-3.43B$-3.48B$-3.71B$-4.22B$-3.54B$-2.76B$-299M
AOCI $-9M$-10M$-14M$-21M$-14M$-13M$-9M$-10M$-21M$-62M
Stockholders' Equity $-1.39B$-1.91B$-1.39B$-1.37B$-1.37B$-1.62B$-2.22B$-1.53B$-767M$1.61B
Liabilities + Equity $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Shares Outstanding 138,626,917138,919,641136,774,911134,703,717132,146,282129,612,117117,822,631116,248,376114,651,004113,876,580
Cashflow 13
Kennzahl Trend 2025202420232022202120202019201820172016
D&A $426M$486M$505M$534M$540M$558M$608M$700M$861M$1.10B
Stock-based Comp $11M$17M$22M$20M$25M$13M$10M$13M$24M$46M
Deferred Tax $-243M$-116M$35M$165M$171M$-187M$203M$-3M$-454M$-116M
Restructuring ····$3M·····
Other Non-cash ······$239M$352M$2.80B$1.83B
Operating Cash Flow $543M$480M$210M$300M$-131M$2.18B$385M$274M$773M$1.14B
CapEx $335M$360M$467M$415M$469M$440M$438M$527M$564M$744M
Investing Cash Flow $847M$-275M$-26M$-259M$-524M$177M$-2M$-245M$1.07B$630M
Net Debt Issued $-6.52B$-5.06B$-4.32B$-2.36B$-4.43B$-5.49B$-3.56B$-2.03B$-5.39B$-6.71B
Financing Cash Flow $-1.17B$-206M$-264M$-430M$-514M$-895M$-363M$-396M$-1.52B$-1.71B
Net Change in Cash $223M$-1M$-80M$-389M$-1.17B$1.46B$20M$-367M$325M$54M
Taxes Paid $249M$171M$91M$-6M$-4M$-2M$3M$19M$-4M$16M
Free Cash Flow $208M$120M$-257M$-115M$-600M$1.74B$-53M$-253M$209M$393M
Rentabilität 7
Kennzahl Trend 2025202420232022202120202019201820172016
Operating Margin 11.9%4.3%7.7%6.7%11.3%9.6%4.9%1.5%··
Net Margin 4.1%-4.1%-1.1%0.38%1.9%4.3%-5.1%-5.6%··
Pretax Margin 5.8%-2.2%1.7%2.9%4.0%3.6%-3.3%-5.1%··
EBITDA Margin 11.9%4.3%7.7%6.7%11.3%9.6%9.5%6.4%··
ROA 3.7%-3.6%-0.91%0.31%1.5%3.2%-4.3%-4.7%-12.5%-7.1%
ROE -30.8%31.2%9.6%-3.4%-15.3%-26.6%36.0%68.5%-580.0%-61.1%
ROIC 15.5%7.3%0.73%4.1%9.6%15.5%8.0%-13.3%206.0%-50.0%
Liquidität & Solvenz 4
Kennzahl Trend 2025202420232022202120202019201820172016
Current Ratio 1.51.41.51.41.51.61.51.51.71.6
Quick Ratio 1.11.01.11.01.11.31.11.11.31.2
Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
LT Debt / Equity -7.4-6.0-8.2-8.5-8.8-7.4-6.0···
Effizienz 2
Kennzahl Trend 2025202420232022202120202019201820172016
Asset Turnover 0.90.90.90.80.80.70.80.8··
Receivables Turnover 5.75.65.86.06.25.65.76.0··
Pro Aktie 5
Kennzahl Trend 2025202420232022202120202019201820172016
Book Value / Share $-10.06$-13.78$-10.18$-10.15$-10.38$-12.54$-18.82$-13.20$-6.69$14.18
Revenue / Share $92.47$95.64$95.75$93.89$94.70$101.15$116.14$125.57··
Cash Flow / Share $4.02$3.63$1.61$2.31$-1.00$18.69$3.38$2.43$6.92$10.27
Cash / Share $1.88$0.27$0.28$0.88$3.84$12.93$1.83$1.69$4.91$2.09
EPS (TTM) $3.77$-3.90$-1.02$0.35$1.76$4.39$-5.93$-6.99$-22.00$-15.54
Wachstumsraten 9
Kennzahl Trend 2025202420232022202120202019201820172016
Revenue YoY -1.2%1.1%2.3%-1.3%4.9%·····
Revenue CAGR 3Y 0.74%0.71%1.9%·······
Revenue CAGR 5Y 1.1%·········
EPS YoY ···-80.1%-59.9%·····
EPS CAGR 3Y 120.8%·········
EPS CAGR 5Y -3.0%·········
Net Income YoY ···-80.0%-55.0%·····
Net Income CAGR 3Y 122.8%·········
Net Income CAGR 5Y -0.08%·········
Bewertung (TTM) 13
Kennzahl Trend 2025202420232022202120202019201820172016
Revenue TTM $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Net Income TTM $509M$-516M$-133M$46M$230M$511M$-675M$-788M$-2.46B$-1.72B
Market Cap $433M$415M$428M$582M$1.76B$963M$342M$328M$488M$637M
Enterprise Value $10.55B$11.81B$11.86B$12.08B$13.36B$11.38B$13.51B···
P/E 0.8-0.8-3.112.37.61.7-0.5-0.4-0.2-0.4
P/S 0.00.00.00.00.10.10.00.00.00.0
P/B -0.3-0.2-0.3-0.4-1.3-0.6-0.2-0.2-0.60.4
P / Cash Flow 0.80.92.01.9-13.40.40.91.20.60.6
P / FCF 2.13.5-1.7-5.1-2.90.6-6.4-1.32.31.6
EV / EBITDA 7.121.812.414.79.510.110.7···
EV / FCF 50.798.4-46.1-105.0-22.36.5-254.9···
EV / Revenue 0.80.90.91.01.11.01.0···
Earnings Yield 120.8%-130.4%-32.6%8.1%13.2%59.1%-204.5%-247.9%-516.4%-278.0%

Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

16
Kennzahl 2025-12-312024-12-312023-12-312022-12-312021-12-31
Umsatz $12.48B $12.63B $12.49B $12.21B $12.37B
Betriebsgewinnmarge % 11.9% 4.3% 7.7% 6.7% 11.3%
Nettoergebnis $509M $-516M $-133M $46M $230M
Verwässerte EPS $3.77 $-3.90 $-1.02 $0.35 $1.76

Institutionelle Eigentümer (13F) 197 Einreicher · $415.1M gesamt · Stand 30. September 2026

17

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Inhaber 197
Gehaltener Wert $415.1M
Neue Positionen 31
Geschlossene Positionen 24
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
Neue Positionen Geschlossene Positionen Erhöht Abgenommen Nettoveränderung der Aktien
31 (+9 vs. Vorquartal) 24 (+4 vs. Vorquartal) 69 (+6 vs. Vorquartal) 54 (-9 vs. Vorquartal) +7.0M

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution Wert Aktien % der verfolgten 13F Typ
CastleKnight Management LP $44.704.517 13.384.586 10,77% Aktien
Apollo Management Holdings, L.P. $39.610.817 11.859.526 9,54% Aktien
BlackRock, Inc. $36.507.995 10.930.538 8,79% Aktien
VANGUARD GROUP INC $28.605.579 9.168.455 6,89% Aktien
Eversept Partners, LP $26.267.680 7.864.575 6,33% Aktien
NOMURA HOLDINGS INC $22.388.384 6.703.109 5,39% Aktien
VANGUARD CAPITAL MANAGEMENT LLC $17.668.370 5.289.931 4,26% Aktien
WHITEBOX ADVISORS LLC $12.467.362 3.732.743 3,00% Aktien
GEODE CAPITAL MANAGEMENT, LLC $10.582.352 3.167.702 2,55% Aktien
STATE STREET CORP $10.226.622 3.061.863 2,46% Aktien
VANGUARD PORTFOLIO MANAGEMENT LLC $10.082.117 3.018.598 2,43% Aktien
Saba Capital Management, L.P. $9.626.444 2.882.169 2,32% Aktien
Owl Creek Asset Management, L.P. $8.452.277 2.530.622 2,04% Aktien
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $8.176.380 2.448.018 1,97% Aktien
DIMENSIONAL FUND ADVISORS LP $7.854.253 2.351.460 1,89% Aktien
D. E. Shaw & Co., Inc. $7.829.388 2.344.128 1,89% Aktien
AQR CAPITAL MANAGEMENT LLC $7.651.362 2.290.827 1,84% Aktien
TWO SIGMA INVESTMENTS, LP $7.365.822 2.205.336 1,77% Aktien
Diameter Capital Partners LP $6.138.793 1.837.962 1,48% Aktien
BANK OF AMERICA CORP /DE/ $5.903.847 1.767.619 1,42% Aktien
GOLDMAN SACHS GROUP INC $5.868.073 1.756.908 1,41% Aktien
TWO SIGMA ADVISERS, LP $5.816.476 1.864.255 1,40% Aktien
CARRONADE CAPITAL MANAGEMENT, LP $5.230.000 1.565.847 1,26% Aktien
Allianz Asset Management GmbH $5.167.919 1.547.281 1,24% Aktien
MORGAN STANLEY $4.800.489 1.437.272 1,16% Aktien
NORTHERN TRUST CORP $4.681.414 1.401.621 1,13% Aktien
Silver Rock Financial LP $3.674.000 1.100.000 0,89% Aktien
CITADEL ADVISORS LLC $3.475.360 1.040.527 0,84% Aktien
Assenagon Asset Management S.A. $2.788.275 834.813 0,67% Aktien
VANGUARD FIDUCIARY TRUST CO $2.642.231 791.087 0,64% Aktien
Jefferies Financial Group Inc. $2.481.286 742.900 0,60% Aktien
Alta Fundamental Advisers LLC $2.161.411 647.129 0,52% Aktien
Bank of New York Mellon Corp $2.122.084 635.354 0,51% Aktien
MARSHALL WACE, LLP $1.906.575 570.831 0,46% Aktien
MILLENNIUM MANAGEMENT LLC $1.701.580 509.455 0,41% Aktien
ExodusPoint Capital Management, LP $1.664.603 498.384 0,40% Aktien
READYSTATE ASSET MANAGEMENT LP $1.657.729 496.326 0,40% Aktien
WOLVERINE ASSET MANAGEMENT LLC $1.339.674 401.100 0,32% Kaufoption
Helix Partners Management LP $1.336.000 400.000 0,32% Aktien
Susquehanna Portfolio Strategies, LLC $1.280.940 383.515 0,31% Aktien
Voleon Capital Management LP $1.247.032 373.363 0,30% Aktien
Invesco Ltd. $1.076.599 322.335 0,26% Aktien
TUDOR INVESTMENT CORP ET AL $999.388 299.218 0,24% Aktien
Pathstone Holdings, LLC $895.621 268.150 0,22% Aktien
Prescott Group Capital Management, L.L.C. $863.076 258.406 0,21% Aktien
UBS Group AG $851.089 254.817 0,21% Aktien
MILLENNIUM MANAGEMENT LLC $835.000 250.000 0,20% Verkaufsoption
FEDERATED HERMES, INC. $812.599 243.293 0,20% Aktien
LPL Financial LLC $737.239 220.730 0,18% Aktien
IEQ CAPITAL, LLC $657.963 196.995 0,16% Aktien

Alle 197 institutionellen Eigentümer anzeigen →

Aktivisten & 5%+-Eigentümer 1 Beteiligung

18

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 Einreichungen 11. März 2021 · Erste Einreichung · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Unternehmensinsider 56 Insider · 29 Führungskräfte · 23 Direktoren

19
Insider Rolle Letzte Aktivität Gehaltene Aktien Käufe 12m Verkäufe 12m Netto 12m
Kevin J Hammons CEO 1. März 2026 A 895.545 0 0 $0
Tim Hingtgen CEO 1. März 2025 A 1.388.781 0 0 $0
Jason K Johnson EVP & CFO 1. März 2026 A 268.439 0 0 $0
Thomas J Aaron EVP and CFO 7. Dezember 2019 F 241.515 0 0 $0
Larry W Cash President and CFO 1. März 2017 A 568.152 0 0 $0
Miguel S Benet President and CMO 1. März 2025 D 47.635 0 0 $0
Austen D Mason Regional President 1. März 2025 A 142.500 0 0 $0
Mark B Medley Regional President 1. März 2025 A 128.637 0 0 $0
Chad A Campbell Regional President 1. März 2025 A 136.815 0 0 $0
Charles J Cova Regional President 1. März 2024 A 58.701 0 0 $0
Lynn T Simon President and CMO 1. März 2024 A 482.657 0 0 $0
Beryl Ramsey Division President 1. März 2019 A 62.969 0 0 $0
Patton Paul Smith Division President 1. März 2019 F 119.017 0 0 $0
Iii John W Mcclellan Division President 1. März 2017 A 41.242 0 0 $0
Robert O Horrar Division President 1. März 2017 A 68.649 0 0 $0
Martin Bonick Division President 1. März 2017 A 100.458 0 0 $0
Michael T Portacci Division President 1. März 2017 A 110.156 0 0 $0
Thomas Daniel Miller Division President 1. März 2016 A 112.107 0 0 $0
David Lewis Miller President and COO 1. März 2016 A 440.840 0 0 $0
William S Hussey Division President 28. Oktober 2015 M 121.568 0 0 $0
Martin Dewayne Smith Division President 3. Juni 2015 M 94.111 0 0 $0
Gary D Newsome Division President - Group Ops 25. August 2008 M 118.286 0 0 $0
David V. Rice EVP-Clinical Operations & CMO 1. Juni 2026 A 30.000 0 0 $0
Phillip A. Posey SVP & CAO 1. März 2026 A 51.736 0 0 $0
Justin D Pitt Pres,Chief Legal&Admin Officer 1. März 2026 A 287.750 0 0 $0
Kevin A Stockton EVP, Operations & Development 1. März 2026 A 208.290 0 0 $0
Rachel A Seifert Executive VP and Secretary 1. März 2017 F 243.065 0 0 $0
Mark T Buford SVP/Chief Accounting Officer 25. Februar 2012 F 78.379 0 0 $0
Martin G Schweinhart Senior Vice President 1. März 2006 A 40.354 0 0 $0
William Norris Jennings Direktor 25. August 2026 S 38.468 0 1 $-118.400
Ranga K Krishnan Direktor 30. Juni 2026 M 170.023 0 0 $0
Fawn D Lopez Direktor 1. März 2026 A · 0 0 $0
Ronald L Burgess JR Direktor 1. März 2026 A · 0 0 $0
Susan W Brooks Direktor 1. März 2026 A 108.695 0 0 $0
Hubert James Williams Direktor 1. März 2026 A 211.863 0 0 $0
Joseph Arthur Hastings Direktor 1. März 2026 A 0 0 0 $0
Elizabeth T Hirsch Direktor 1. März 2026 A 162.059 0 0 $0
James S. Ely III Direktor 1. März 2026 A 412.876 0 0 $0
John A Fry Direktor 1. März 2026 A 268.966 0 0 $0
John A Clerico Direktor 1. März 2026 A 368.763 0 0 $0
Michael Dinkins Direktor 1. März 2026 A 225.882 0 0 $0
Wayne T Smith Direktor 1. März 2026 A 5.217.579 0 0 $0
Julia B North Direktor 1. März 2021 A 162.056 0 0 $0
Mitchell H Watson JR Direktor 16. Mai 2017 M 22.594 0 0 $0
Harvey Klein MD Direktor 15. März 2010 M 10.383 0 0 $0
Dale F Frey Direktor 31. März 2008 A 20.000 0 0 $0
Thomas H Lister Direktor 21. September 2004 S 0 0 0 $0
Thodore Forstmann Direktor 21. September 2004 S 0 0 0 $0
Sandra Horbach Direktor 21. September 2004 S 0 0 0 $0
Robert J Dole Direktor 6. Mai 2004 S 0 0 0 $0
FLC XXIX PARTNERSHIP LP 10%-Eigentümer 21. September 2004 S 0 0 0 $0
FLC XXX PARTNERSHIP LP 10%-Eigentümer 21. September 2004 S 0 0 0 $0
Winston Hutchins 10%-Eigentümer 21. September 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO SUB DEBT & EQU MGMT BUYOUT PART VI LP 10%-Eigentümer 21. September 2004 S 0 0 0 $0
FORSTMANN LITTLE & CO EQUITY PARTNERSHIP V L P 10%-Eigentümer 21. September 2004 S 0 0 0 $0
Benjamin C Fordham · 1. März 2021 A 254.608 0 0 $0

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

ETF-Besitz Gehalten von 25 ETFs

20

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
BSJR · Invesco Exchange-Traded Self-Indexe… 2,68% 23.297.000 1. Oktober 2026 Täglich
EBIT · Harbor ETF Trust 0,45% 19.210 NS 31. Juli 2026 N-PORT
IWC · iShares Trust 0,09% 443.690 SH 11. September 2026 Täglich
IHF · iShares Trust 0,05% 223.947 SH 11. September 2026 Täglich
VTWV · VANGUARD SCOTTSDALE FUNDS 0,03% 113.109 SH 19. August 2026 Täglich
NEAR · iShares U.S. ETF Trust 0,03% 1.340.000 SH 11. September 2026 Täglich
PRFZ · Invesco Exchange-Traded Fund Trust 0,02% 226.491 SH 1. Oktober 2026 Täglich
IWM · iShares Trust 0,01% 3.425.206 SH 11. September 2026 Täglich
RSSL · Global X Funds 0,01% 62.038 NS 31. Juli 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 746.733 SH 19. August 2026 Täglich
VHT · VANGUARD WORLD FUND 0,01% 349.881 SH 19. August 2026 Täglich
DFAS · Dimensional ETF Trust 0,01% 289.348 NS 31. Juli 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 202.789 NS 31. Juli 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 33.838 NS 31. Juli 2026 N-PORT
ITOT · iShares Trust 0,00% 203.848 SH 11. September 2026 Täglich
IWV · iShares Trust 0,00% 42.177 SH 3. September 2026 Täglich
DCOR · Dimensional ETF Trust 0,00% 6.184 NS 31. Juli 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 31.135 NS 31. Juli 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 1.347.195 SH 19. August 2026 Täglich
VTI · VANGUARD INDEX FUNDS 0,00% 3.813.888 SH 19. August 2026 Täglich
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 9.817 SH 19. August 2026 Täglich
DFSU · Dimensional ETF Trust 0,00% 24 NS 31. Juli 2026 N-PORT
VGHY · VANGUARD FIXED INCOME SECURITIES FU… · · 15. Juli 2026 Täglich
VPLS · VANGUARD MALVERN FUNDS · · 15. Juli 2026 Täglich
IWN · iShares Trust · 1.223.127 SH 11. September 2026 Täglich

CYH Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

21
Bewertung · 16 Analysten HALTEN
Median-Ziel $3.12 +14,9%
1 6,2% Starker Kauf
1 6,2% Kauf
6 37,5% Halten
7 43,8% Verkauf
1 6,2% Starker Verkauf

12-Monats-Kursziel

8 Analysten · 2026-10-01

Mittelwert-Ziel $3.16 +16,0%

Jetzt Aktueller Preis $2.72
Tief$2.00 Mittelwert$3.16 Hoch$4.00

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

22

FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
CYH $433M 0.8 -1.2% 4.1% -30.8% ·
SGRY $2.00B -25.3 6.2% -2.4% -4.5% ·
NUTX $1.17B 15.7 82.4% 8.1% 30.6% 50.8%
ARDT $1.26B 9.2 6.0% 2.1% 11.2% ·
USPH · 55.0 16.3% 5.1% 8.2% 19.2%
STLN · · · · · ·
JYNT $123M 45.9 5.2% 5.3% 16.3% ·
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·

Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen

23

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

26

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Quelle: SEC 10-Q eingereicht Jul 23, 2026